STAT

Experts challenge the science behind ban on psychiatrists discussing politicians’ mental health

A prohibition against psychiatrists discussing the mental health of public figures is “premised on dubious scientific assumptions,” researchers concluded.
Photos of Sen. Barry Goldwater during his 1964 campaign for president.

A prohibition against psychiatrists discussing the mental health of public figures — a rule that has become especially controversial, and sometimes flouted, since the inauguration of President Trump — is “premised on dubious scientific assumptions,” researchers concluded in an analysis scheduled for publication in a psychology journal.

The American Psychiatric Association (APA) defends its “” by arguing that an in-person psychiatric examination is the gold standard for diagnosing mental illness and psychological traits — given that there are no blood tests or brain scans for psychiatric disorders. In fact, however, numerous studies suggest that the interview-based exam can be misleading, psychologist Scott Lilienfeld of Emory University and colleagues argue in the

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Brain Biopsies On ‘Vulnerable’ Patients At Mount Sinai Set Off Alarm Bells At FDA, Documents Show
A STAT Investigation: Brain biopsies on "vulnerable" patients at Mount Sinai set off alarm bells at FDA, documents show.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Senate Probe Into Novo Pricing, A New UTI Antibiotic, And More
The U.S. Senate health committee is investigating the prices Novo Nordisk charges for its blockbuster medications Ozempic and Wegovy.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About CVS And Humira Biosimilars, Schumer’s Broken Insulin Promise, And More
New prescriptions for biosimilar versions of Humira, one of the best-selling drugs in the U.S., surged to 36% from just 5% during the first week of April.

Related Books & Audiobooks